Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma. [electronic resource]
Producer: 20101020Description: 4283-90 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- analysis
- Central Nervous System Neoplasms -- drug therapy
- Cyclophosphamide -- analysis
- Disease-Free Survival
- Doxorubicin -- analysis
- Drug Administration Schedule
- Female
- Humans
- Injections, Intravenous
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Prednisone -- analysis
- Recurrence
- Risk
- Rituximab
- Vincristine -- analysis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.